These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 856308)

  • 1. [Activation of plasma Factor XIII by acetylated thrombin].
    Orlova AS; Baskova IP
    Biokhimiia; 1977 Feb; 42(2):297-9. PubMed ID: 856308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of factor XIII by beta-thrombin].
    Umarova BA; Strukova SM
    Biokhimiia; 1979 Aug; 44(8):1524-9. PubMed ID: 497297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor XIII as a stimulator of thrombin activity].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1976; 22(4):562-6. PubMed ID: 1027244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M; Nyman D; Krajnc V; Duckert F
    Thromb Haemost; 1977 Aug; 38(2):438-46. PubMed ID: 579487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS.
    Sabo TM; Brasher PB; Maurer MC
    Biochemistry; 2007 Sep; 46(35):10089-101. PubMed ID: 17691819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease.
    Lynch GW; Pfueller SL
    Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form.
    Schroeder V; Vuissoz JM; Caflisch A; Kohler HP
    Thromb Haemost; 2007 Jun; 97(6):890-8. PubMed ID: 17549290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
    Isetti G; Maurer MC
    Biochemistry; 2007 Mar; 46(9):2444-52. PubMed ID: 17286389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation.
    Trumbo TA; Maurer MC
    Biochemistry; 2002 Feb; 41(8):2859-68. PubMed ID: 11851434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin inhibits the activation of factor XIII by thrombin.
    Polgár J; Léránt I; Muszbek L; Machovich R
    Thromb Res; 1986 Sep; 43(5):685-90. PubMed ID: 3018957
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 17. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin.
    Takagi T; Doolittle RF
    Biochemistry; 1974 Feb; 13(4):750-6. PubMed ID: 4811064
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of blood coagulation factor XIII.
    Lorand L
    Ann N Y Acad Sci; 1986; 485():144-58. PubMed ID: 3471146
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Interactions of factor XIII subunits as studied by affinity chromatography.
    McDonagh J; McDonagh RP
    Thromb Diath Haemorrh; 1975 Nov; 34(2):549-50. PubMed ID: 1198416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.